Defendant

Handa Pharmaceuticals, Inc.

2 cases as defendant.

Cases
2
Active
1
1 closed
Filed
2022
Top venue
D. Delaware
2 cases

Novartis Pharmaceuticals Corp. v. Handa Neuroscience, LLC et al.

Discovery active through mid-2022; final disposition unverified
Docket:
1:21-cv-00645

Suit against Handa entities asserting the '405 patent and also US 10,543,179. Handa sought summary judgment on the '405 patent after the Federal Circuit's June 2022 invalidation; final disposition not verified.